American College of Cardiology (ACC) Conference in Orlando

Late-Breaking-Clinical-Trial Session

"Eprotirome as a Novel and Physiological Approach to CVD Risk Reduction: Beneficial Effects on Lipoprotein Levels When Added to Statin Therapy."

Press release
News flash - Eprotirome (excerpt)
Read more about ACC 2009»